mountsinaihospital.com
This postdoctoral position focuses on investigating the role of TENM3 in the pathogenesis of diabetic kidney disease using systems biology approaches. The role involves utilizing in vitro cell cultures and in vivo animal models to confirm the critical function of TENM3 in podocyte injury. The position is based at the Icahn School of Medicine at Mount Sinai within the Department of Medicine/Nephrology.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for mountsinaihospital.com.
8% above the average for this role